116
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Expression of serglycin in human disc is increased in degenerated discs and up-regulated in vitro by exposure to IL-1ß or TNF-α

&

References

  • Gruber HE, Fisher EC Jr, Desai B, Stasky AA, Hoelscher G, Hanley EN (1997) Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-b1. Exp. Cell. Res. 235: 13–21.
  • Gruber HE, Johnson T, Norton HJ, Hanley EN Jr (2002a) The sand rat model for disc degeneration: radiologic characterization of age-related changes. Cross-sectional and prospective analyses. Spine 27: 230–234.
  • Gruber HE, Johnson TL, Leslie K, Ingram JA, Martin D, Hoelscher G, Banks D, Phieffer L, Coldham G, Hanley EN Jr (2002b) Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine 27: 1626–1633.
  • Gruber HE, Hoelscher GL, Leslie K, Ingram JA, Hanley EN Jr (2006) Three-dimensional culture of human disc cells within agarose or a collagen sponge: assessment of proteoglycan production. Biomaterials 27: 371–376.
  • Gruber HE, Ingram J, Hoelscher GL, Norton HJ, Hanley EN Jr (2007) Cell polarity in the annulus of the human intervertebral disc. Morphologic, immunocytochemical, and molecular evidence. Spine 32: 1287–1294.
  • Gruber HE, Hoelscher GL, Ingram JA, Morton DS, Hanley EN Jr (2013) Human annulus cells regulate PAPP-A and IGFBP-4 expression, and thereby insulin-like growth factor bioavailability, in response to proinflammatory cytokine exposure in vitro. Connec. Tissue Res. 54: 432–438.
  • Bachmeier BE, Nerlich A, Mittermaier N, Weiler C, Lumenta C, Wuertz K, Boos N (2009) Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur. Spine J. 18: 1573–1586.
  • Hoshi H, Shimawaki K, Takegawa Y, Phyanagi T, Amano M, Hinou H, Nishimura S-I (2012) Molecular shuttle between extracellular and cytoplasmic space allows for monitoring of GAG biosynthesis in human articular chondrocytes. Biochim. Biophys. Acta 1820: 1391–1398.
  • Hoyland JA, Le Maitre C, Freemont AJ (2008) Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology 47: 809–814.
  • Imoto-Tsubakimoto H, Takahashi T, Ueyama T, Ogata T, Adachi A, Nakanishi N, Mitushima K, Naito Y, Matsubara H (2013) Serglycin is a novel adipocytokine highly expressed in epicardial adipose tissue. Biochim. Biophys. Acta 432: 105–110.
  • Kolset SO, Tveit H (2008) Serglycin−structure and biology. Cell. Molec. Life Sci. 65: 1073–1085.
  • Korpetinou A, Skandalis SS, Labropoulou VT, Smirlaki G, Noulas A, Karamanos NK, Theocharis AD (2014) Serglycin: at the crossroad of inflammation and malignancy. Front. Oncol. 3. article 327.
  • LeMaitre CL, Hoyland JA, Freemont AJ (2007) Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1ß and TNFa expression profile. Arthr. Res. Ther. 9/4: R77.
  • Lemire JM, Chan CK, Bressler S, Miller J, LeBaron RG, Wight TN (2007) Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. J. Cell. Biochem. 101: 753–766.
  • Li X, Ong CK, Cao Y, Xiang YQ, Shao JY, Ooi A, Peng LX, Lu WH, Zhang Z, Petillo DQL, Bao Y, Zheng FJ, Chia CS, Iyer NG, Kang TB, Zeng YX, Soo KC, Trent JM, Teh BT, Qian CN (2011) Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res. 71: 3162–3172.
  • Lundequist A, Abrink M, Pejler G (2006) Mast cell-dependent activation of pro-matrix metalloprotease 2: a role for serglycin proteoglycan-dependent mast cell proteases. Biol. Chem. 387: 1513–1519.
  • Mall N, Berg E, Theocharis AD, Svineng G, Uhlin-Hansen L, Winberg J-O (2013) In vitro reconstruction of complexes between pro-matrix metalloproteinase-9 and the proteoglycans serglycin and versican. FEBS J. 280: 2870–2887.
  • Meen AL, Oynebraten I, Reine TM, Duelli A, Svennevig K, Pejler G, Jenssen T, Kolset SO (2011) Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROa/CXCL1. J. Biol. Chem. 286: 2636–2647.
  • Melo FR, Grujic M, Spirkoski J, Calounova G, Pejler (2012) Serglycin proteoglycan promotes apoptotic versus necrotic cell death in mast cell. J. Biol. Chem. 287: 18142–18152.
  • Merline R, Schaefer RM, Schaefer L (2009) The matricellular function of small leucine-rich proteoglycans (SLRPs). J. Cell. Commun. 3: 323–335.
  • Omtvedt LA, Kolset SO, Thoen J, Forre Y, Gill M (2001) Serglycin expression in CD2+ and CD14+ cells from patients with various rheumatic diseases. Scand. J. Rheumatol. 30: 164–166.
  • Rein TM, Vuong TT, Rutkovskly A, Meen AJ, Vaage J, Jenssen TG, Kolset SO (2015) Serglycin in quiescent and proliferating primary endothelial cells. PLoS ONE 10(12): e0145584.
  • Reine TM, Vuong TT, Jenssen TG, Kolset SO (2014) Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro. Biochim. Biophys. Acta 1840: 2498–2505.
  • Schick BP, Ho H-CK, Brodbeck KC, Wrigle CW, Klimas J (2003) Serglycin proteoglycan expression and synthesis in embryonic stem cells. Biochim. Biophys. Acta 1593: 259–267.
  • Scully OJ, Chua P-J, Harve KS, Bay B-H, Yip GW (2012) Serglycin in health and diseases. Anat. Rec. 295: 1415–1420.
  • Skliris A, Labropoulou VT, Papachristou DJ, Aletras A, Karamanos NK, Theocharis AD (2013) Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases. Febs J. 280: 2342–2352.
  • Thompson JP, Pearce RH, Schechter MT, Adams M, Tsang IKY, Bishop PB (1990) Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine 15: 411–415.
  • Zhang L, Yang M, Yan D, Cavey G, Davidson P, Gibson G (2010) Molecular interactions of MMP-13 C-terminal domain with chondrocyte proteins. Connec. Tissue Res. 51: 230–239.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.